StockData
GLAUKOS Corp logo

GLAUKOS Corp (GKOS) stock

GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30203% above fair value
$233.08−10.17 (-4.18%)

Close on Nov 18, 2026Market cap $13.80BP/E –Yield –

Glaukos net income

Net income is the profit left for shareholders after every expense, interest and tax.

Glaukos's net income for the twelve months ending Sep 30, 2026 was -$169.80M. For fiscal 2025 it was -$187.69M. The highest annual figure on record is $15.42M in fiscal 2019.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$187.69M–
FY2024Dec 31, 2024-$146.37M–
FY2023Dec 31, 2023-$134.66M–
FY2022Dec 31, 2022-$99.20M–
FY2021Dec 31, 2021-$49.59M–
FY2020Dec 31, 2020-$120.35M-880.3%
FY2019Dec 31, 2019$15.42M–
FY2018Dec 31, 2018-$12.95M–
FY2017Dec 31, 2017-$92.00K-102.0%
FY2016Dec 31, 2016$4.52M–
FY2015Dec 31, 2015-$37.24M–
FY2014Dec 31, 2014-$12.13M–
FY2013Dec 31, 2013-$12.64M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$2.02M–
Q2 FY2026Jun 30, 2026-$18.38M–
Q1 FY2026Mar 31, 2026-$19.78M–
Q4 FY2025Dec 31, 2025-$133.66M–
Q3 FY2025Sep 30, 2025-$16.23M–
Q2 FY2025Jun 30, 2025-$19.66M–
Q1 FY2025Mar 31, 2025-$18.15M–
Q4 FY2024Dec 31, 2024-$33.58M–
Q3 FY2024Sep 30, 2024-$21.41M–
Q2 FY2024Jun 30, 2024-$50.55M–
Q1 FY2024Mar 31, 2024-$40.84M–
Q4 FY2023Dec 31, 2023-$36.78M–
Q3 FY2023Sep 30, 2023-$30.44M–
Q2 FY2023Jun 30, 2023-$32.81M–
Q1 FY2023Mar 31, 2023-$34.63M-744.0%
Q4 FY2022Dec 31, 2022-$31.46M–
Q3 FY2022Sep 30, 2022-$27.58M-542.6%
Q2 FY2022Jun 30, 2022-$45.54M–
Q1 FY2022Mar 31, 2022$5.38M–
Q4 FY2021Dec 31, 2021-$21.87M–
Q3 FY2021Sep 30, 2021$6.23M–
Q2 FY2021Jun 30, 2021-$17.48M–
Q1 FY2021Mar 31, 2021-$16.47M–
Q4 FY2020Dec 31, 2020-$10.65M-129.1%
Q3 FY2020Sep 30, 2020-$15.75M–
Q2 FY2020Jun 30, 2020-$39.89M–
Q1 FY2020Mar 31, 2020-$54.06M–
Q4 FY2019Dec 31, 2019$36.58M+1956.3%
Q3 FY2019Sep 30, 2019-$13.51M–
Q2 FY2019Jun 30, 2019-$6.31M–
Q1 FY2019Mar 31, 2019-$1.34M–
Q4 FY2018Dec 31, 2018$1.78M+76.8%
Q3 FY2018Sep 30, 2018-$6.62M-599.7%
Q2 FY2018Jun 30, 2018-$5.40M–
Q1 FY2018Mar 31, 2018-$2.71M-408.8%
Q4 FY2017Dec 31, 2017$1.01M+650.7%
Q3 FY2017Sep 30, 2017$1.33M–
Q2 FY2017Jun 30, 2017-$3.30M–
Q1 FY2017Mar 31, 2017$878.00K–
Q4 FY2016Dec 31, 2016$134.00K–

More Glaukos figures

See a number that looks wrong?